Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The FDA &ldquo;remains committed&rdquo; to reviewing and approving investigational drugs through its expanded access&nbsp;program, which will continue in conjunction with the recently enacted federal Right to Try law.</p>

Right to Try Law Raises Questions About FDA, IRB Oversight

‘IRB review may be more necessary for patient protection’